Search

Search Constraints

You searched for: Author/Creator Prins, Robert M

Search Results

1. 214 Noninvasive Monitoring of Immunotherapeutic Responses in Glioblastoma Using Novel Imaging Techniques. Issue Volume 65:Issue CN(2018)Supplement 1 (16th August 2018)

2. CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy. Issue 1 (16th December 2014)

4. Cytokine responsiveness of CD8+ T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients. Issue 1 (13th May 2014)

5. Dendritic Cell Vaccination is Effective Against H3.3G34R Mutant Glioblastoma in a Novel Syngeneic Genetically Engineered Mouse Model. (16th November 2020)

6. Diffusion MRI is an early biomarker of overall survival benefit in IDH wild-type recurrent glioblastoma treated with immune checkpoint inhibitors. Issue 6 (2nd December 2021)

8. Engineering T Cell Receptors to Target H3.3G34 Mutant Glioblastoma. (16th November 2020)

10. Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRI. Issue 9 (4th May 2019)